However, patients with BRCA1 mutations tend to have a higher risk of developing ovarian cancer by the age of 80; 44% (95% C.I, 36%-53%) for BRCA1 and 17% (95% C.I, 11%-25%) for BRCA2 [17]. The gene discussed is BRCA2; the disease is ovarian carcinoma.